- Home
- DTIL
as 07-11-2025 2:32pm EST
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | DURHAM |
| Market Cap: | 51.6M | IPO Year: | 2019 |
| Target Price: | $47.00 | AVG Volume (30 days): | 546.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.61 - $11.09 | Next Earning Date: | 07-31-2025 |
| Revenue: | $51,141,000 | Revenue Growth: | -11.11% |
| Revenue Growth (this year): | -67.38% | Revenue Growth (next year): | 30.20% |
Latest Precision BioSciences Inc. News
DTIL Breaking Stock News: Dive into DTIL Ticker-Specific Updates for Smart Investing
Argus Research
12 days ago
Daily – Vickers Top Buyers & Sellers for 06/30/2025
MT Newswires
17 days ago
US Equity Futures Rise Ahead of Powell Testimony
MT Newswires
17 days ago
Top Premarket Gainers
Business Wire
17 days ago
Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy
Yahoo Finance Video
a month ago
Will Tesla have to play catch up to Waymo's robotaxis?
Yahoo Finance
a month ago
Why Scott Bessent wants to make it easier for banks to own Treasurys
GlobeNewswire
a month ago
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
GlobeNewswire
a month ago
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Compare DTIL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DTIL Precision BioSciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.